How to Measure “Short-Term Hormonal Effects”?

Background. Interest to assess short-term benefits or risks of sex-steroid hormone use (OC or HRT) exists for years. However, no validated scale is available to evaluate the broad array of described effects of short-term hormone use. Methods. A raw scale consisting of 43 specific items and 47 genera...

Full description

Bibliographic Details
Main Author: Lothar A. J. Heinemann
Format: Article
Language:English
Published: Hindawi Limited 2009-01-01
Series:Obstetrics and Gynecology International
Online Access:http://dx.doi.org/10.1155/2009/459485
id doaj-67fd2a34ead24e1b8b338ebcb850a724
record_format Article
spelling doaj-67fd2a34ead24e1b8b338ebcb850a7242020-11-24T22:23:15ZengHindawi LimitedObstetrics and Gynecology International1687-95891687-95972009-01-01200910.1155/2009/459485459485How to Measure “Short-Term Hormonal Effects”?Lothar A. J. Heinemann0Centre for Epidemiology & Health Research Berlin ZEG, Invalidenstrasse 115, D-10115 Berlin, GermanyBackground. Interest to assess short-term benefits or risks of sex-steroid hormone use (OC or HRT) exists for years. However, no validated scale is available to evaluate the broad array of described effects of short-term hormone use. Methods. A raw scale consisting of 43 specific items and 47 general data was developed. Surveys in Italy, Germany and Austria were performed and data analyzed by factorial analyses. The resulting new scale with 15 items underwent reliability and validity investigations. Results. The new scale consists of 15 items in 5 domains. Internal consistency reliability coefficients were satisfactory as were test-retest reliability coefficients. Content and concurrent validity were promising. Conclusion. Psychometric properties of the new scale suggest good characteristics to measure short-term effects of sex-steroid hormones in women. The scale seems to be appropriate, feasible, interpretable, reliable, and valid for their application as PRO scale.http://dx.doi.org/10.1155/2009/459485
collection DOAJ
language English
format Article
sources DOAJ
author Lothar A. J. Heinemann
spellingShingle Lothar A. J. Heinemann
How to Measure “Short-Term Hormonal Effects”?
Obstetrics and Gynecology International
author_facet Lothar A. J. Heinemann
author_sort Lothar A. J. Heinemann
title How to Measure “Short-Term Hormonal Effects”?
title_short How to Measure “Short-Term Hormonal Effects”?
title_full How to Measure “Short-Term Hormonal Effects”?
title_fullStr How to Measure “Short-Term Hormonal Effects”?
title_full_unstemmed How to Measure “Short-Term Hormonal Effects”?
title_sort how to measure “short-term hormonal effects”?
publisher Hindawi Limited
series Obstetrics and Gynecology International
issn 1687-9589
1687-9597
publishDate 2009-01-01
description Background. Interest to assess short-term benefits or risks of sex-steroid hormone use (OC or HRT) exists for years. However, no validated scale is available to evaluate the broad array of described effects of short-term hormone use. Methods. A raw scale consisting of 43 specific items and 47 general data was developed. Surveys in Italy, Germany and Austria were performed and data analyzed by factorial analyses. The resulting new scale with 15 items underwent reliability and validity investigations. Results. The new scale consists of 15 items in 5 domains. Internal consistency reliability coefficients were satisfactory as were test-retest reliability coefficients. Content and concurrent validity were promising. Conclusion. Psychometric properties of the new scale suggest good characteristics to measure short-term effects of sex-steroid hormones in women. The scale seems to be appropriate, feasible, interpretable, reliable, and valid for their application as PRO scale.
url http://dx.doi.org/10.1155/2009/459485
work_keys_str_mv AT lotharajheinemann howtomeasureshorttermhormonaleffects
_version_ 1725765206639902720